Publications by authors named "Camilla Eek"
Mult Scler Relat Disord
July 2022
Article Synopsis
- Teriflunomide (Aubagio®) is a once-daily oral medication for treating relapsing multiple sclerosis (MS), and a study called Teri-LIFE evaluated its impact on patients' quality of life in real-world settings.
- The study involved 200 patients from Nordic countries, measuring changes in quality of life using the SF-36 questionnaire over 24 months, along with various secondary outcomes like treatment satisfaction and adherence.
- Results showed stable quality of life scores, reduced relapse activity, and high treatment adherence; patients generally found teriflunomide acceptable, with some differences observed between treatment-naïve and previously treated patients.
